Podcasts about rush university system

Host Matt Fisher talks to Dr. Paul Casey, Chief Medical Officer, Rush University System for Health, Ben Wolfe, Director of Digital Transformation, Rush University System for Health and Sonia Singh, Chief Insights Officer, AVIA. They discuss Keys to planning for and implementing digital transformation; development of intentional approach for transformation; considerations for involving all key stakeholders; development of governance structure to oversee and guide digital transformation; recognizing and incorporating patient feedback. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, Carl Bergetz, JD, Chief Legal Officer and Board Secretary at Rush University System for Health, discusses the complex intersection of law, ethics, and healthcare operations. From balancing mission and margin to addressing regulatory challenges and the evolving role of AI in health law, Carl shares invaluable insights on leadership, institutional trust, and the future of healthcare compliance.

Can the Promise of AI Match the Hype? ROI and Lessons From Initial Use Cases at RUSH On this episode Jeff Gautney, Senior Vice President & Chief Information Officer at Rush University System for Health talks to host Ben Hilmes about his career path from consulting to leading IT at a top academic medical center. He breaks down Rush's digital transformation strategy—leveraging AI and automation, modernizing infrastructure, and driving operational efficiency. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, Ihsan Kaadan, MD, MS, discusses how he and Rush clinicians provide tailored, wraparound care for patients with peripheral artery disease (PAD) and chronic venous insufficiency. We also profile Dr. Kaadan's unique role in guiding Rush's multidisciplinary approach to treat these conditions, where he works with cardiologists, vascular surgeons and interventional radiologists to deliver optimal patient care. Dr Kaadan is a vascular medicine specialist in the Rush University System for Health; he evaluates and treats patients with complex arterial and vein disorders. “It's a one-stop shop at Rush, which sets us apart. A patient can come to the vascular medicine clinic, get evaluated for their disease, then start treatment either with me or one of my colleagues in cardiology or interventional radiology. Patients can also receive cardiac rehab and occupational and physician therapy, so they're supported throughout their entire experience

This episode, recorded live at the Becker's Healthcare 9th Annual Health IT + Digital Health + RCM Annual Meeting, features Anil Saldanha, Chief Innovation Officer at Rush University System for Health. Here, he discusses how AI technologies like scribing and conversational AI are enhancing healthcare delivery, the importance of data integration tools like Epic and FHIR, and the need for collaboration and openness to innovation as healthcare systems navigate future advancements.

This episode, recorded live at the Becker's Healthcare 9th Annual Health IT + Digital Health + RCM Annual Meeting, features Anil Saldanha, Chief Innovation Officer at Rush University System for Health. Here, he discusses how AI technologies like scribing and conversational AI are enhancing healthcare delivery, the importance of data integration tools like Epic and FHIR, and the need for collaboration and openness to innovation as healthcare systems navigate future advancements.

In this episode, Matt Walsh, EVP & COO of Rush University System for Health, shares his vision for strengthening health equity, building system-wide consistency, and leading with innovation in a complex healthcare environment. Matt also reflects on the evolving role of a COO and his thoughts on leadership, resilience, and collaboration in tackling healthcare's toughest challenges.

Danny Luger, MD, is a cardiologist in the Rush University System for Health and the co-founder of the Rush Metabolic Health Consortium. He runs the Rush Center for Prevention of Cardiovascular Disease at Rush Oak Park whose goal is to prevent patients from developing cardiac disease. When meeting with patients, Dr. Luger helps them identify their barrier to achieving a healthy lifestyle, whether it is sedentary behavior, multiple risk factors for cardiovascular disease, high blood pressure, high cholesterol, or diabetes. After getting to know his patients, he creates individualized medical plans to help them overcome those factors. “The model that we're trying to put forth is preventive, where we can engage people in health and wellness well before they develop manifestations of disease. Eighty percent of cardiovascular disease is preventable, so we know this is an effective strategy. It's a matter of changing the way that our system approaches chronic diseases and the way that patients conceptualize seeing a doctor.”

Join us for an insightful conversation with Jeff Gautney, Senior Vice President & Chief Information Officer at Rush University System for Health, as he shares his background and current priorities. Jeff discusses the evolution of his organization over the next 2-3 years and highlights a transformative change made by his team that has yielded significant results.

Join us for an insightful conversation with Jeff Gautney, Senior Vice President & Chief Information Officer at Rush University System for Health, as he shares his background and current priorities. Jeff discusses the evolution of his organization over the next 2-3 years and highlights a transformative change made by his team that has yielded significant results.

January 2: Today on TownHall Sue Schade, Principal at StarBridge Advisors speaks with Jeff Gautney, Senior Vice President and CIO at Rush University System for Health as a follow up to their last conversation in September. They delve into Jeff's diverse career, his approach to integrating artificial intelligence within a healthcare setting, and the challenges of an integrated academic medical center. How can we ensure that AI-driven patient care and future integration is conducted in a safe, efficient, and holistic manner? How does the integration of university functions with healthcare systems add layers of complexity to identity management and more?Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

David Ansell's book “The Death Gap: How Inequality Kills” was first published in 2017. In a foreword for the book updated in 2020, Chicago Mayor Lori Lightfoot wrote that “Three years before the COVID-19 crisis, Dr. David Ansell published The Death Gap, brilliantly synthesizing what he experienced in decades of practicing medicine in two utterly different medical worlds that were mere blocks apart. What makes this book so compelling is that rather than focusing exclusively on data and statistics, Dr. Ansell makes these gruesome numbers real. He tells the story of the disparities through the real-life experiences of patients with whom he had deep, committed relationships.”  In today's discussion Dr. Ansell reflects on the collision between the ongoing epidemic of social and structural determinants of health, and the pandemic of COVID-19. He also shares recommendations for ways that healthcare providers can bring together quality, safety and equity in medicine.  David A. Ansell, MD, MPH, is Senior Vice President for Community Health Equity for Rush University Medical Center and Associate Provost for Community Affairs for Rush University System for Health, Chicago.  Dr. Carla Harwell is Medical Director, University Hospitals Otis Moss Jr. Health Center; Associate Professor of Medicine, CWRU School of Medicine, Division of Internal Medicine; and Vice Chair for the Board of Directors at Movement is Life.  (c) Movement is Life 2023

Power of Partnerships: Part 3 Jeremy Strong, System Vice President, Supply Chain & Hospital Operations at Rush University System for Health joins Justin, Mike and Vicky to discuss Rush Health's innovative JumpHire program, the concept, success and subsequent second cohort that just started and their continued focus on community engagement and investment in local businesses and alignment with those business to meet Rush Health's operational priorities.

October 5: Today on TownHall Sue Schade, Principal at StarBridge Advisors speaks with Jeff Gautney, Senior Vice President and CIO at Rush University System for Health. What have been some recent key accomplishments for his IT team and what are their current priorities? How is his team addressing AI so that they are assessing the value and not chasing shiny objects? How has Jeff's extensive consulting background helped him effectively as he transitioned into his role as CIO?Join us for our webinar "Interoperability Outcomes: A Discussion of What's Possible" on October 5th at 1 PM ET/10 AM PT, discussing challenges in healthcare interoperability. We'll tackle key issues like fragmented technology systems, data privacy, and cost-effectiveness. Engage with top-tier experts to understand the current landscape of healthcare IT, learn data-driven strategies for patient-centered care, and discover best practices for ensuring system security and stakeholder trust. Register Here - https://thisweekhealth.com/interoperability-outcomes/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Clinicians in the RUSH Cancer Center are continually providing tailored cancer treatment to their patients. In today's episode with Jessica Slostad, MD, a breast oncologist in the RUSH University System for Health, she profiles one possible, future avenue for personalized medicine--organoid drug screening. Although they are still being evaluated, tumor organoid drug screening may play a key role in the evolution of personalized cancer care. This type of screening could help clinicians test the effectiveness and side effects of therapies prior to giving them to patients. Later in the episode, she profiles the ways she treats women with pregnancy-associated breast cancer, along with the unique challenges mothers and their babies encounter during treatment. Dr. Slostad is an assistant professor of Medicine in the Division of Hematology, Oncology and Cellular Therapy at RUSH and specializes in breast cancer management. Her research interests include clinical and translational research with a focus on precision oncology and organoid technology. “As we get more data and if [that data] supports the hypothesis that tumor organoids can be used as a drug screen to predict response, we would eventually look to see if we can use the tumor organoid to pick which therapy for the patient. Our data is not there yet; we first need to establish that there is concordance between the drug screen and what the patient is getting.” CME Link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/490159/

In this episode Molly Gamble chats with Dr. Omar Lateef, President and CEO of RUSH University System for Health and RUSH University Medical Center. Here, he discusses what makes RUSH special, being a leader during and after the pandemic, what really defines good healthcare, how to assess when healthcare organizations are improving health equity in their communities, and more.

RUSH electrophysiologists treat patients with atrial fibrillation through a number of pharmacologic, non-surgical and surgical approaches, while also helping them modify risk factors to slow down progression of this chronic disease. Our providers treat newly diagnosed, paroxysmal, persistent and permanent atrial fibrillation. RUSH clinicians coordinate patients' care before, during and after treatment, tailoring a multidisciplinary treatment plan that specifically meets their needs. Dr. Erica Engelstein is an electrophysiologist in the RUSH University System for Health and an expert in treating atrial fibrillation. Her clinical interests include evaluation and treatment of patients with suspected or documented arrhythmias, including catheter ablation of atrial fibrillation and ventricular tachycardia. “Some patients are best managed with rate control and anticoagulation so that we don't expose those patients unnecessarily to an invasive procedure. However, if the chances of restoring and maintaining a normal heart rhythm are good--and a lot of patients fit that profile--then they may be better managed with a more aggressive approach including catheter ablation.” CME Link:  https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/488912/ 

Jeff Gautney, Senior Vice President & CIO at Rush University System for Health, joins the podcast to discuss his background & 38 years in the healthcare industry, how he is leveraging technology to improve his organization, different ways he is looking at retaining staff, and more.Want to network with peers and hear more conversations like this? Apply to be one of our complimentary guest reviewers at our upcoming HIT + Digital Health + RCM Meeting Oct, 3-6 2023 here.

Jeff Gautney, Senior Vice President & CIO at Rush University System for Health, joins the podcast to discuss his background & 38 years in the healthcare industry, how he is leveraging technology to improve his organization, different ways he is looking at retaining staff, and more.Want to network with peers and hear more conversations like this? Apply to be one of our complimentary guest reviewers at our upcoming HIT + Digital Health + RCM Meeting Oct, 3-6 2023 here.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Rush University System for Health is planning a new outpatient center that would cover part of Chicago and suburbs. It would be built at the site of the old Sears store at North and Harlem in the city’s Galewood neighborhood. The […]

Critical limb ischemia is the end stage of peripheral arterial disease (PAD). With early detection and intervention of PAD, RUSH providers can prevent critical limb ischemia and major amputation for patients. RUSH is one of the only academic medical centers in Chicago and the Midwest to perform complex revascularization to restore blood flow and salvage limbs. Kumar Madassery, MD, is the director of the Peripheral Vascular Interventions and Critical Limb Ischemia Program in the RUSH University System for Health. He is also an associate professor of Vascular Interventional Radiology and is the director of the Advanced Vascular Interventional Radiology Fellowship at RUSH. “One providers specialize in treating patients with peripheral arterial disease that has progressed where they need some type of surgical or endovascular intervention. Over the last 10 to 15 years, we've seen an exponential growth of revascularization strategies and techniques that have helped to save patients from amputation.” CME Link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/488817/ 

This episode features Tatyana Popkova,  Chief Strategy Officer at Rush University System for Health & Shaista Malik, Executive Director at Susan Samueli Integrative Health Institute; Associate Vice Chancellor, Integrative Health at UCI Health. Here, they discuss their backgrounds, what health systems have to excel at in order to be great, their biggest priorities going into the end of the year, and more.

Dr. Ranga Krishnan is the former CEO of the RUSH University System for Health, and currently serves as Senior Advisor to the CEO.  He is a national leader in medical education – known for his efforts to reconceptualize traditional medical classroom learning.  For four years, he served as dean of the RUSH Medical College, and for eight years led the Duke-N.U.S. Graduate Medical School Singapore, a joint venture between Duke University and the National University of Singapore.    You'll want to hear his approach for creating an engaging, first-class medical education that significantly lowers costs and reduces barriers to recruiting educators. A psychiatrist by training, Dr. Krishnan also gives his take on the mental health crisis our nation is facing. 

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Rush University System for Health is expanding into Indiana. Crain’s reports Rush and Franciscan Alliance have entered a partnership to expand the availability of cancer and neuroscience care to patients in northwest Indiana.  Also, Caterpillar has reached a civil settlement with […]

RUSH University System for Health has a high-volume program for breast cancer treatment and reconstruction, incorporating a multidisciplinary approach that involves our plastic surgery, surgical oncology and medical oncology teams. This approach ensures our patients are treated with a coordinated, individualized care plan. RUSH also performs a wide range of leading-edge implant and flap breast reconstruction procedures after mastectomy or lumpectomy. Rosalinda Alvarado, MD, is a breast surgeon experienced in breast conserving surgery, mastectomy including nipple-sparing mastectomy, oncoplastic surgery, sentinel node biopsy and breast cancer prevention and risk reduction. Deana Shenaq, MD, specializes in both implant-based and autologous reconstruction after breast cancer and in microvascular techniques for lymphedema treatment, including lymph node transfer and lymphovenous bypass procedures. “It's very important that Dr. Alvarado does what she needs to do to get the cancer out safely and have a negative margin,” says Dr. Shenaq. “My main goal is not only to prevent recurrence, but also to do the reconstruction in the most aesthetically pleasing way possible.” CME link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/486749

The RUSH University System for Health is nationally recognized for its delivery of timely, effective stroke care and expertise in treating some of the most complex stroke cases. Within the past year, three multidisciplinary subspecialty clinics were opened at RUSH to provide an even greater level of specialty stroke care for patients. Rima Dafer, MD, is a vascular neurologist and the director of the Comprehensive Outpatient Cerebrovascular Diseases Clinic at RUSH University Medical Center. She has been a principal investigator on numerous clinical trials in acute stroke intervention and secondary stroke prevention. Her clinical interests center around stroke occurrence in young adults and the association of stroke and atrial fibrillation. “Our stroke-cardiology and stroke-neurosurgery clinics provide patients with a personalized individualized care plan tailored to their unique needs depending on their condition. And our stroke prevention clinic plays such an important role in helping patients understand very simple risk factors that aid in primary stroke prevention.”   CME link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/486244

Tom Robertson, Executive Director of the Vizient Research Institute is joined by an old friend, Mike Dandorph, President and CEO of Tufts Medicine in Boston. Before assuming his current role, Mike was President, Rush University System for Health and Rush University Medical Center in Chicago, and prior to that he was the long-time chief strategist for the University of Pennsylvania Health System in Philadelphia. Mike shares his thoughts on leadership, comparing experiences in different models of AMCs. The conversation then turns to macroeconomic challenges facing the American health care system and Mike's views relative to potential systemic changes.   Guest speaker: Michael J. Dandorph, MHA President and CEO Tufts Medicine Moderator: Tom Robertson Executive Director Vizient Research Institute   Show Notes: [00:50] Organizational structure is less important than staff alignment for a health system's success [3:47] Tufts Medicine aims to treat their patients as consumers and organizes for accountability, quality outcomes and invests with patient priorities [4:10] Other key components are: physician alignment, incentives rewarding the right behavior and putting the right people in the right positions    [5:40] Culture plays a role in keeping the patient the center of attention as opposed to research   [07:34] Mergers and acquisitions: integration is really hard because it requires a lot of change, and humans don't like to change [8:56] In mergers, clinical teams need to come together to address programmatic integration, performance improvement, service rationalization and that takes trust. Leaders can help by creating an environment with honest conversations. [11:10] U.S. health system higher costs aren't translating into better access or better quality of care. It's not just a provider issue, but a societal issue. Resources need to be deployed in a way that has a higher impact than it has now.  [14:08] Rate regulation won't change the social determinant issues, but if health care organizations don't control costs, the government may intervene   [17:44] Supply-induced demand is not the health's industries big problem, it's very sick people. Instead, where we take care of patients need to be considered to cut costs   [19:56] During the pandemic health care organizations came together in a broader ecosystem to provide the best care [23:21] The current health system is so complex that it will have to be partially dismantled to be more rational.  The insurers have gotten in the middle and that creates a huge administrative expense.  20% of costs is attributed to billing preapprovals and authorizations.   Links | Resources: Michael J. Dandorph's biographical information   Subscribe Today! Apple Podcasts Amazon Podcasts Google Podcasts Android Spotify Stitcher RSS Feed

The movement disorders neurology group at RUSH University Medical Center is one of the largest and most experienced groups in the world, with clinicians who specialize in managing the symptoms of Parkinson's disease and other movement disorders. One of the treatment modalities they use to treat these patients is deep brain stimulation (DBS). DBS helps patients with movement disorders control their symptoms of tremor, rigidity, stiffness, slowed or abnormal movements and walking problems. RUSH treats the largest number of DBS patients in the Midwest. Dr. Neepa Patel is a neurologist in the RUSH University System for Health and the director for the Movement Disorder Interventional Program in the Department of Neurological Sciences. Her interests include improving the quality and delivery of care for patients receiving deep brain stimulation (DBS) and education to improve the utilization of new therapies in movement disorders. She is also part of the RUSH team caring for essential and Parkinsonian tremor patients with MR-guided focused ultrasound, an incisionless treatment designed to reduce hand tremor. “We work in a very comprehensive, multidisciplinary, team-based approach at RUSH to treat patients with movement disorders using DBS. We share our ideas and experiences because everyone comes from different training backgrounds, different expertise and years of experience in managing patients. This helps us take care of patients who are nontraditional, but who still could benefit from this therapy.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/484707/  

Dr. Ranga Krishnan of Rush University System for Health discusses the future of mental health payment and practice. He addresses how provider organizations can address workforce shortages by becoming partners in training and by changing the way they provide care to patients. He also talks about improving mental and behavioral healthcare in a value-based payment environment. Mentioned in this episode: Taking care of your mental health when you hit the pandemic wall The future of the clinical workforce: Joyce Fitzpatrick, Case Western Reserve University, and Robyn Begley, CEO of the AONL and chief nursing officer of the AHA, discuss challenges in nursing Student Enrollment Surged in U.S. Schools of Nursing in 2020 Despite Challenges Presented by the Pandemic

Cardiac positron emission tomography (PET) perfusion with flow quantification is the latest advancement in nuclear stress testing and is used to examine how well blood flows to the heart muscle. RUSH is the first and only hospital in Illinois to offer this technology. Dr. Rupa Sanghani, a cardiologist in the RUSH University System for Health, discusses the ways RUSH incorporates cardiac PET perfusion in its complement of cardiac diagnostics and care, the benefits of using it and when cardiac PET should be implemented. Dr. Sanghani is the director of RUSH University Medical Center's nuclear cardiology and stress laboratory and the associate director for the RUSH Heart Center for Women. Her clinical expertise is in cardiac imaging, cardiovascular risk assessment and counseling, coronary artery disease and with women who either have heart disease or are at risk for it. “It's a huge boon to offer our patients and referring physicians cardiac PET perfusion. We can use information from it to provide patients with a comprehensive risk assessment for their cardiac health. Flow and flow reserve is what people are most excited about with PET. The advantage to cardiac PET is that we're not just looking at relative perfusion, but we can actually quantitate the myocardial blood flow.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/483393

This episode of Tuning Healthcare features Anthony Del Rio, the President of Rush Health, the Clinically Integrated Network of Rush University System for Health (RUSH). As Senior Associate General Counsel and Managing Director at RUSH, Anthony also oversaw the Business Development and Transactions team, where he managed multiple hospital affiliations and joint ventures with large healthcare entities. Prior to joining RUSH, Anthony represented healthcare clients at an international law firm with a focus on mergers and acquisitions. He also worked as a management consultant for large healthcare systems, helping develop and manage hospitals in multiple states. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This episode of Tuning Healthcare features Anthony Del Rio, the President of Rush Health, the Clinically Integrated Network of Rush University System for Health (RUSH). As Senior Associate General Counsel and Managing Director at RUSH, Anthony also oversaw the Business Development and Transactions team, where he managed multiple hospital affiliations and joint ventures with large healthcare entities. Prior to joining RUSH, Anthony represented healthcare clients at an international law firm with a focus on mergers and acquisitions. He also worked as a management consultant for large healthcare systems, helping develop and manage hospitals in multiple states. Anthony discusses RUSH's pivot to value and how the health system clinically integrated network controls costs, supports the mission of managing populations and delivers better outcomes for the patient.

This episode features K. Ranga Rama Krishnan,CEO at Rush University System for Health. Here, he discusses his career, current priorities, what he's excited about for the future, and more.

Launched in 2020, RUSH's breast cancer risk assessment program systematically assesses the risk of breast cancer, offering patients who qualify opportunities for supplemental screening in order to improve their breast cancer detection rate. Mia Levy, MD, PhD, the director of the Cancer Center at RUSH University Medical Center and the system vice president for cancer services at the RUSH University System for Health, joins the podcast to talk about RUSH's program, what she sees as the evolution for this type of learning system at RUSH, and what are some of the early findings--and questions--that have come up thus far. “We want to learn from the experiences of every patient who's coming through our breast cancer screening program--not just the patients who are participating in clinical trials. In this way, we are optimizing our workflows and data collection to evaluate the outcomes of the program and continuously improve on our screening guidelines and our workflows in order to optimize the best outcomes for our patients.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/482640

The healthcare industry is ripe for disruption and major change. Key players in this space are looking for innovative ways to improve quality, access, and efficiency of care provided. My guest today, Anthony Del Rio, is a leader in the healthcare industry and is working to disrupt the status quo through bold leadership and innovative ideas. For company leaders looking to transform their healthcare businesses, this episode will provide inspiration and practical advice on how to do so. Anthony Del Rio is the President and Executive Director of Rush Health and a professor at Rush University. Anthony obtained his Bachelor’s degree in Business from Georgia State University and his Juris Doctor from Duke University School of Law. He practiced law for several years before joining the Rush University System of Health network. What We Discussed in This Episode: How Anthony took on his new leadership position at Rush Health right at the start of the Covid-19 pandemic What’s the best way to formulate a strategic vision for a company? Is there financial benefit to population health management? Why the historic structure of healthcare is no longer serving the public? What’s the best way a company leader can assess risk before moving forward with instituting innovative strategies? What will it take for larger healthcare companies to adopt inventive care programs? How is technology assisting in the administration of population health management? Why assessing data and analytics can help provide better care? The role of courage in leadership Resources Mentioned: Intermountain Healthcare  Contact Information: Rush Health  Anthony’s LinkedIn profile  Thank you for listening! Don’t forget to FOLLOW the show to receive every new episode delivered straight to your podcast player every week. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show in Apple Podcasts, Amazon Music, Stitcher Radio, Google Podcasts, or Spotify.  It helps other listeners find this show. Be sure to connect with us and reach out with any questions/concerns: LinkedIn Facebook Twitter  Sheppard Mullin website This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

As pioneers in the treatment of multiple sclerosis and other neurologic conditions, RUSH delivers life-changing treatment for patients in its state-of-the-art infusion program. Thomas Shoemaker, MD, a neurologist in the RUSH University System for Health, joins Rounding at Rush to discuss RUSH's infusion program, what he and his colleagues have learned about infusions during the COVID-19 pandemic and where the future of neurologic treatments is heading at RUSH. Dr. Shoemaker specializes in treating neuro-immunologic conditions such as multiple sclerosis, neuromyelitis optica spectrum disorder, neurosarcoidosis and acute disseminated encephalomyelitis. The RUSH Multiple Sclerosis Center has been recognized as a Center for Comprehensive Care through the National Multiple Sclerosis Society. Rush's Neurology and Neurosurgery programs, which include the MS Center and infusion program, are ranked number four in the nation and best in Illinois by U.S. News and World Report. “For our MS patients, it seemed like our only treatment was IV corticosteroids for the longest time, which would often require inpatient admission for three to five days,” explains Dr. Shoemaker. “In the infusion center, we can quickly administer corticosteroids and IV immunoglobulins to many patients on an outpatient basis so that they can go home for the day and return again on an outpatient basis to finish their treatment. Infusing patients this way naturally makes it less cumbersome on them.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/482333   

Rounding at Rush welcomes John O'Toole, MD, to the show to discuss spinal tumor care at RUSH University Medical Center. RUSH is known for its use of minimally invasive procedures, interdisciplinary nature that streamlines care and success in creating better quality of life outcomes for its patients. Dr. O'Toole is a neurosurgeon in the RUSH University System for Health, specializing in spinal oncology, minimally invasive spine surgery, complex spinal reconstruction and spinal radiosurgery. He is the Co-Director of the Coleman Foundation Comprehensive Spine Tumor Clinic and a Professor in the Department of Neurosurgery at RUSH Medical College. “We reduce morbidity, recovery times and blood loss through the use of minimally invasive surgical techniques,” says Dr. O'Toole. “For the cancer population we treat, that's incredibly important. These patients don't have a lot of time to recover from major operations before they get on to radiation treatments and other systemic treatments for their cancer. We've been leaders in the use of these techniques, making a big difference in both the short-term and long-term outcomes for patients with spinal tumors.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/482099

Parikshit Sharma, MD, MPH, joins Rounding at Rush to discuss His bundle and conduction system pacing, which involves placing permanent leads anywhere along the AV conduction system to maintain biventricular pacing and synchrony. Dr. Sharma is a cardiac electrophysiologist at RUSH University System for Health who specializes in managing rhythm disorders of the heart. He is the section chief of cardiac electrophysiology, the director of the electrophysiology lab and an associate professor of medicine at RUSH Medical College. “We can decrease heart failure hospitalizations in patients with His bundle pacing compared to right ventricular pacing,” says Dr. Sharma. “And while right ventricular pacing can be associated with adverse clinical outcomes, such as cardiomyopathy, heart failure hospitalizations, atrial fibrillation and associated mortality, His bundle pacing can essentially prevent a lot of them from occurring.” CME credit link: https://cmetracker.net/RUSH/Publisher?page=pubOpen#/EventID/481815